Jiangsu Hengrui Medicine Co., Ltd.;Shanghai Hengrui Pharmaceutical Co., Ltd
发明人:
申请号：
EP18875520.1
公开号：
EP3712170A1
申请日:
2018.11.09
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Provided are a CD96 antibody, an antigen-binding fragment and a pharmaceutical use thereof. Further provided are a murine antibody, a chimeric antibody and a humanized antibody comprising the CDR region of the CD96 antibody, and a pharmaceutical composition comprising the CD96 antibody and the antigen-binding fragment thereof, and the use of same as a drug. In particular, provided is a use of a humanized CD96 antibody in the preparation of a drug for treating CD96-related diseases or conditions.
